The PNPLA3 genotype interacts with both nonmodifiable (age, sex, genetic ancestry) and modifiable risk factors (visceral adiposity, obesity, insulin resistance, lipids) to multiplicatively increase risk of hepatic steatosis (66) (Figure 2). The gene discussed is PNPLA3; the disease is obesity disorder.